Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-08-19
1996-09-10
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, 424 852, 530380, A61K 3816
Patent
active
055545904
ABSTRACT:
A method of treating asthma in a subject in need of such treatment comprises contacting Asthma Reversal Factor to the respiratory epithelium of the subject. The active agent is preferably contacted to the subject's respiratory epithelium by causing the subject to inhale respirable particles comprised of the active agent.
REFERENCES:
Reddingari et al., Clin. Res., vol. 40(2), p. 228A, Abstract, 1992.
Alam et al., The Faseb Journal, Abstracts, vol. 6 (2), pp. A2005, Feb. 1992. (abstract No. 6188).
Kuna et al., Jour. Allergy & Clin. Immunol., vol. 87 (1), part 1, p. 207 (abstract #272), Jan. 1991.
Brindley, L L et al., J. Clin. Invest., vol. 72, pp. 1218-1223, 1983.
Kuna et al., T. Exp. Med., vol. 175, pp. 489-493, 1992 Feb.
Alam et al., Jour. Allergy & Clin. Immunol., vol. 87(1), part 1, p. 241, 1991.
Alam et al J. Clin. Invest. vol. 82 (Dec. 1988) pp. 2056-2062.
Fisher et al J. Allergy Clin Immunol. vol. 79, p. 196 (1987) Abstract.
Kuna et al., IL-8 Inhibits Histamine Release from Human Basophils Induced By Histamine-Releasing Factors, Connective Tissue Activating Peptide III, and IL-3.sup.1, The Journal of Immunology, vol. 147, 1920-1924, No. 6, Sep. 1991.
Alam et al., Study of the Cellular Origin of Histamine Release Inhibitory Factory Using Highly Purified Subsets of Mononuclear Cells.sup.1, The Journal of Immunology, Crawley, vol. 143, 2280-2284, No. 7, Oct. 1989.
Alam et al., Detection of Histamine Release Inhibitory Factor--and Histamine Releasing Factor-like Activities in Bronchoalveolar Lavage Fluids, AM REV RESPIR DIS 1990; 141:666-671.
Schroder et al., Lipopolysaccharide-Stimulated Human Monocytes Secrete, Apart From Neutrophil-Activating Peiptide 1/Interleukin 8, A Second Neutrophil-Activating Protein, J. Exp. Med., vol. 171, Apr. 1990, 1091-1100.
Wolpe et al., Macrophage Inflammatory Proteins 1 and 2: Members of a Novem Superfamily of Cytokines, The FASEB Journal, vol. 3, Dec. 1989.
SICA et al., Mono Chemotactic and Activating Factor Gene Expression Induced In Endothelial Cells By IL-1 and Tumor Necrosis Factor, The Journal of Immunology, vol. 144, 3034-3038, No. 8, Apr. 15, 1990.
Schall et al., Selective Attraction of Monocytes and T Lymphocytes of the Memory Phenotype by Cytokine RANTES, Nature, vol. 347, 18 Oct. 1990.
Mukaida et al., Regulation of Human Interleukin 8 Gene Expression and Binding of Several Other Members of the Intercrine Family to Receptors for Interleukin-8 Chemotactic Cytokines, Advances in Exp. Med. & Biol., Plenum Press, pp. 31-38, 1991.
Schall et al., A Human T Cell-Specific Molecule is a Member of a New Gene Family, The Journal of Immunology, vol. 141, 1 018-1025, No. 3, Aug. 1, 1988.
Hechtman et al., Intravascular IL-8, Inhibitor of Polymorphonuclear Leukocyte Accumulation at Sites of Acute Inflammation, The Journal of Immunology, vol. 147, 883-892, Aug. 1, 1991.
Oppenheim et al., Properties of the Novel Proinflammatory Supergene "Intercine" Cytokine Family, Annu. Rev. Immunol. 1991, 9:617-48.
Alam et al., Effect of 8KD Family of Cytokines on Basophil/Mast Cell Histamine Release: Macrophage Inflammatory Protein-1 (MIP-1) Has Histamine Releasing Activity, Clinical Research, vol. 40, No. 2, 1992.
Kaplan et al., Int. Arch. Allergy Appl. Immunol., vol. 94, pp. 148-153, 1991.
Baeza et al., J. Clin. Invest., vol. 85, pp. 1516-1521, 1990.
Walz et al., J. Exp. Med., vol. 171, pp. 449-454, 1990.
Kaplan et al., Clin. Exp. Allergy, vol. 21 (Suppl. 1), pp. 8-16, 1991.
Reddingari et al., J. Allergy Clin. Immunol., vol. 87(1), Part 1, #406, 1991.
Fisher Robert H.
Henriksen Ruth A.
Metzger W. James
East Carolina University
Sayala Chhaya D.
LandOfFree
Method of treating asthma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating asthma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating asthma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320423